{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:18:19Z","timestamp":1773875899744,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s40261-026-01531-5","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:54:15Z","timestamp":1772628855000},"page":"407-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Over-the-Counter Product Use Among Individuals with Vitiligo: A Cross-Sectional International Survey"],"prefix":"10.1007","volume":"46","author":[{"given":"N. O.","family":"Enwereji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. C.","family":"Opaigbeogu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Ceresnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. C.","family":"Ezekwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Elbuluk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0671-4774","authenticated-orcid":false,"given":"Richard H.","family":"Huggins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"issue":"9988","key":"1531_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(14)60763-7.","journal-title":"Lancet"},{"issue":"2","key":"1531_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.det.2016.11.002","volume":"35","author":"N Elbuluk","year":"2017","unstructured":"Elbuluk N, Ezzedine K. Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients. Dermatol Clin. 2017;35(2):117\u201328. https:\/\/doi.org\/10.1016\/j.det.2016.11.002.","journal-title":"Dermatol Clin"},{"issue":"1","key":"1531_CR3","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1111\/bjd.15881","volume":"178","author":"E McManus","year":"2018","unstructured":"McManus E, Sach T, Levell NJ. Are vitiligo treatments cost-effective? A systematic review. Br J Dermatol. 2018;178(1):e57\u20138. https:\/\/doi.org\/10.1111\/bjd.15881.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1531_CR4","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/bjd.14204","volume":"174","author":"N Silpa-Archa","year":"2016","unstructured":"Silpa-Archa N, Griffith JL, Williams MS, Lim HW, Hamzavi IH. Prospective comparison of recipient-site preparation with fractional carbon dioxide laser vs dermabrasion and recipient-site dressing composition in melanocyte-keratinocyte transplantation procedure in vitiligo: a preliminary study. Br J Dermatol. 2016;174(4):895\u20137. https:\/\/doi.org\/10.1111\/bjd.14204.","journal-title":"Br J Dermatol"},{"key":"1531_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108789","volume":"109","author":"X Liu","year":"2022","unstructured":"Liu X, Yao Z, Wang Y, Chai L, Zhou X. Vitamin D analogs combined with different types of phototherapy in the treatment of vitiligo: a systematic review of randomized trials and within-patient studies. Int Immunopharmacol. 2022;109:108789. https:\/\/doi.org\/10.1016\/j.intimp.2022.108789.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"1531_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/1346-8138.14244","volume":"45","author":"A Watabe","year":"2018","unstructured":"Watabe A, Yamasaki K, Asano M, et al. Efficacy of oral cholecalciferol on rhododendrol\u2010induced vitiligo: a blinded randomized clinical trial. J Dermatol. 2018;45(4):456\u201362. https:\/\/doi.org\/10.1111\/1346-8138.14244.","journal-title":"J Dermatol"},{"key":"1531_CR7","unstructured":"Definition of complementary and alternative medicine\u2014NCI Dictionary of Cancer Terms\u2014NCI. Published February 2, 2011. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/complementary-and-alternative-medicine. Accessed 21 Mar 2024."},{"issue":"5","key":"1531_CR8","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1089\/acm.2013.0327","volume":"20","author":"ET Landis","year":"2014","unstructured":"Landis ET, Davis SA, Feldman SR, Taylor S. Complementary and alternative medicine use in dermatology in the United States. J Altern Complement Med. 2014;20(5):392\u20138. https:\/\/doi.org\/10.1089\/acm.2013.0327.","journal-title":"J Altern Complement Med"},{"issue":"3","key":"1531_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jaad.2008.11.905","volume":"60","author":"N Smith","year":"2009","unstructured":"Smith N, Shin DB, Brauer JA, Mao J, Gelfand JM. Use of complementary and alternative medicine among adults with skin disease: results from a national survey. J Am Acad Dermatol. 2009;60(3):419\u201325. https:\/\/doi.org\/10.1016\/j.jaad.2008.11.905.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1531_CR10","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jamadermatol.2018.2972","volume":"154","author":"AC Gamret","year":"2018","unstructured":"Gamret AC, Price A, Fertig RM, Lev-Tov H, Nichols AJ. Complementary and alternative medicine therapies for psoriasis: a systematic review. JAMA Dermatol. 2018;154(11):1330\u20137. https:\/\/doi.org\/10.1001\/jamadermatol.2018.2972.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1531_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ctcp.2011.05.003","volume":"18","author":"AN Kalaaji","year":"2012","unstructured":"Kalaaji AN, Wahner-Roedler DL, Sood A, et al. Use of complementary and alternative medicine by patients seen at the dermatology department of a tertiary care center. Complement Ther Clin Pract. 2012;18(1):49\u201353. https:\/\/doi.org\/10.1016\/j.ctcp.2011.05.003.","journal-title":"Complement Ther Clin Pract"},{"key":"1531_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.clnesp.2016.05.006","volume":"15","author":"G Karag\u00fczel","year":"2016","unstructured":"Karag\u00fczel G, Sakarya NP, Bahad\u0131r S, Yaman S, \u00d6kten A. Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: a prospective study. Clin Nutr ESPEN. 2016;15:28\u201331. https:\/\/doi.org\/10.1016\/j.clnesp.2016.05.006.","journal-title":"Clin Nutr ESPEN"},{"issue":"3","key":"1531_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","volume":"28","author":"D Parsad","year":"2003","unstructured":"Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol. 2003;28(3):285\u20137. https:\/\/doi.org\/10.1046\/j.1365-2230.2003.01207.x.","journal-title":"Clin Exp Dermatol"},{"key":"1531_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-11-21","volume":"11","author":"O Szczurko","year":"2011","unstructured":"Szczurko O, Shear N, Taddio A, Boon H. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Complement Altern Med. 2011;11:21. https:\/\/doi.org\/10.1186\/1472-6882-11-21.","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"1531_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5114\/ada.2017.67073","volume":"34","author":"MR Mogaddam","year":"2017","unstructured":"Mogaddam MR, Ardabili NS, Maleki N, Chinifroush MM, Fard EM. Evaluation of the serum zinc level in patients with vitiligo. Adv Dermatol Allergol. 2017;34(2):116\u20139. https:\/\/doi.org\/10.5114\/ada.2017.67073.","journal-title":"Adv Dermatol Allergol"},{"issue":"2","key":"1531_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.det.2016.11.012","volume":"35","author":"PE Grimes","year":"2017","unstructured":"Grimes PE, Nashawati R. The Role of Diet and Supplements in Vitiligo Management. Dermatol Clin. 2017;35(2):235\u201343. https:\/\/doi.org\/10.1016\/j.det.2016.11.012.","journal-title":"Dermatol Clin"},{"issue":"4","key":"1531_CR17","first-page":"e63","volume":"12","author":"HB Kwon","year":"2013","unstructured":"Kwon HB, Choi Y, Kim HJ, Lee AY. The therapeutic effects of a topical tretinoin and corticosteroid combination for vitiligo: a placebo-controlled, paired-comparison, left-right study. J Drugs Dermatol JDD. 2013;12(4):e63-67.","journal-title":"J Drugs Dermatol JDD"},{"issue":"18","key":"1531_CR18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","volume":"280","author":"DM Eisenberg","year":"1998","unstructured":"Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280(18):1569\u201375. https:\/\/doi.org\/10.1001\/jama.280.18.1569.","journal-title":"JAMA"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01531-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-026-01531-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-026-01531-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:35:31Z","timestamp":1773848131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-026-01531-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1531"],"URL":"https:\/\/doi.org\/10.1007\/s40261-026-01531-5","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data sharing statement"}},{"value":"No financial support was received for the conduct of this study, or for the preparation or publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding sources"}},{"value":"RHH has been an investigator for Arcutis, Avita, Clinuvel, Incyte, Pfizer, Mitsubishi, and The Immune Tolerance Network. He is also the Community-Physician Liason\u00a0of the Global Vitiligo Foundation (GVF) and the chair of the GVF Community committee and served on advisory boards for Incyte and Avita. MSC is a sub-investigator for Avita Medical, Incyte Corporation, Clinuvel Pharmaceuticals, and the Immune Tolerance Network (funding paid to institution). Dr. Elbuluk has served as a consultant, advisory board member, and\/or speaker for Avita, Scientis, Incyte, VisualDx, La Roche Posay, Beiersdorf, Unilever, Eli Lilly, Galderma, Pfizer, L\u2019Oreal, McGraw Hill, Dior, Medscape, Abbvie, Takeda, Sanofi, Janssen, Kenvue, Kao. She has received royalties from McGraw-Hill. She has stock options in VisualDx. She is a board member of the Global Vitiligo Foundation (GVF) and chair of the GVF communications committee. AG, NCE, NOE, and OCO have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Reviewed and approved by the Henry Ford Health Institutional Review Board (#14941-). This study was performed in accordance with the standards of the ethics outlined in the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Participants were required to read a \u201cconsent to participate\u201d statement and check a box to opt-in to the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Concept and design\u2014all authors; Acquisition, analysis, or interpretation of data\u2014all authors; Drafting of the manuscript\u2014all authors; Critical review of the manuscript for important intellectual content\u2014all authors; Statistical analysis\u2014all authors; All authors read and approved the final version and agree to be accountable for the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}